Effects of Cissampelos sympodialis Eichl. and its alkaloid, warifteine, in an experimental model of respiratory Allergy to Blomia tropicalis

Current Drug Targets

Volumn 11, Issue 11, 2010, Pages 1458-1467

  Cerqueira Lima, Ana Tereza ^a   Alcântara Neves, Neuza Maria ^a   de Carvalho, Lain Carlos Pontes ^b   Costa, Ryan Santos ^a   Barbosa Filho, José Maria ^c   Piuvezam, Márcia ^c   Russo, Momtchilo ^d   Barboza, Renato ^d   de Jesus Oliveira, Eduardo ^c   Marinho, Alexsandro ^c   Figueiredo, Camila Alexandrina ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Asthma; Blomia tropicalis; Cissampelos sympodialis; Cytokines; Natural products; Warifteine

Indexed keywords

ALKALOID; ALLERGEN; ANTIASTHMATIC AGENT; CISSAMPELOS SYMPODIALIS EXTRACT; EOSINOPHIL PEROXIDASE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PLANT EXTRACT; UNCLASSIFIED DRUG; WARIFTEINE; CYTOKINE;

ALLERGIC ASTHMA; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BLOMIA TROPICALIS; CELL COUNT; CELL DIFFERENTIATION; CISSAMPELOS; CISSAMPELOS SYMPODIALIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RETENTION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; RAT; SKIN ANAPHYLAXIS; A J MOUSE; ANIMAL; ASTHMA; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MITE; PLANT LEAF; THEORETICAL MODEL; WISTAR RAT;

ALKALOIDS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CISSAMPELOS; CYTOKINES; EOSINOPHIL PEROXIDASE; FEMALE; IMMUNOGLOBULIN E; MICE; MICE, INBRED A; MITES; MODELS, THEORETICAL; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR;

EID: 79954986918     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111009011458     Document Type: Article

References (45)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351(9111): 1225-32.
2. Ernst E. Complementary therapies in asthma: what patients use. J Asthma 1998; 35: 667-71.
3. Bielory L, Lupoli K. Review article: herbal interventions in asthma and allergy. J Asthma 1999; 36: 1-65.
4. Bezerra-Santos CR, Balestieri FM, Rossi-Bergmann B, Peçanha LM, Piuvezam MR. Cissampelos sympodialis Eichl. (Menispermaceae): oral treatment decreases IgE levels and induces a Th1-skewed cytokine production in ovalbumin-sensitized mice. J Ethnopharmacol 2004; 95(2-3): 191-7.
5. Bezerra-Santos CR, Peçanha LMT, Piuvezam MR. Cissampelos sympodialis Eichl. (Menispermaceae) inhibits anaphylactic shock reaction in murine allergic model. Rev Bras Farmacogn 2005; 15: 287-91.
6. Bezerra-Santos CR, Vieira-de-Abreu A, Barbosa-Filho JM, Bandeira-Melo C, Piuvezam MR, Bozza PT. Anti-allergic properties of Cissampelos sympodialis and its isolated alkaloid warifteine. Int Immunopharmacol 2006; 6(7): 1152-60
7. Barbosa-Filho JM, Agra MF, Thomas G. Botanical, chemical and pharmacological investigation on Cissampelos species from Paraíba (Brazil). Cienc Cult 1997; 49: 386-94.
8. Piuvezam MR, Peçanha LMT, Alexander J, Thomas G. Cissampelos sympodialis Eichl. leaf extract increases the production of IL-10 by concanavalin-A treated BALB/c spleen cells. J Ethnopharmacol 1999; 67: 93-101.
9. Alexandre-Moreira MS, Freire de Lima CG, Trindade NM, Castro-Faria-Neto HC, Piuvezam MR, Peçanha LMT. Cissampelos sympodialis Eichl. (Menispermaceae) leaf extract induces interleukin-10-dependent inhibition of Trypanosoma cruzi killing by macrophages. Braz J Med Biol Res 2003; 36: 199-205.
10. Batista-Lima KV, Ribeiro RA, Balestieri FMP, Thomas G, Piuvezam MR. Anti-inflammatory activity of Cissampelos sympodialis Eichl. (Menispermaceae) leaf extract, Acta Farmaceutica Bonaerense 2001; 20: 275-9.
11. Costa HF, Bezerra-Santos CR, Barbosa Filho JM, Martins MA, Piuvezam MR. Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals. Int Immunopharmacol 2008; 8: 519-25.
12. Carvalho AF, Fusaro AE, Oliveira CR, Brito CA, Duarte AJS, Sato MN. Blomia tropicalis and Dermatophagoides pteronyssinus mites evoke distinct patterns of airway cellular influx in type i hypersensitivity murine model. J Clin Immunol 2004; 24(5): 533-41.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
14. Mukherjee R, Keifer PA. Warifteine and methylwarifteine: H-1 and C-13 assignments by two-dimensional NMR spectroscopy. Magn Reson Chem 2003; 41(3): 213-18.
15. Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997; 17: 404-13.
16. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985; 83: 209-15.
17. Vasconcelos JF, Teixeira MM, Barbosa-Filho, et al. The triterpenoid lupeol attenuates allergic airway inflammation in a murine model. Int Immunopharmacol 2008; 8: 1216-21.
18. Holt PG, Rose AH, Batty JE, Turner KJ. Induction of adjuvant independent IgE responses in inbred mice: primary, secondary, and persistent IgE responses to ovalbumin and ovomucoid. Int Arch Allergy Appl Immunol 1981; 65: 42-50.
19. Vieira-de-Abreu A, Amendoeira FC, Gomes GS, et al. Antiallergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. Int Immunopharmacol 2005; 5(13-14): 1966-74.
20. Butcher, EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
21. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-600.
22. Baqueiro T, Russo M, Silva VM, et al. Respiratory allergy to Blomia tropicalis: immune response in four syngeneic mouse strains and assessment of a low allergen-dose, short-term experimental model. Respir Res 2010; 11: 51.
23. Gonzalo JA, Lloyd CM, Kremer L, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. J Clin Invest 1996; 98: 2332-45.
24. Sohn SH, Ko E, Oh BG, et al. Inhibition effects of Vitex rotundifolia on inflammatory gene expression in A549 human epithelial cells. Ann Allergy Asthma Immunol 2009; 103(2): 152.
25. Lee JS, Lee CM, Jeong YI, et al. D-pinitol regulates Th1/Th2 balance via suppressing Th2 immune response in ovalbumininduced asthma. FEBS Lett 2007; 581: 57-64.
26. Medeiros KC, Figueiredo CA, Figueredo TB, et al. Anti-allergic effect of bee pollen phenolic extract and myricetin in ovalbuminsensitized mice. J Ethnopharmacol 2008; 119(1): 41-6.
27. Thomsen AR, Sottrup-Jensen L, Gleich GJ. Oxvig, C. The status of half-cystine residues and locations of N-glycosylated asparagine residues in human eosinophil peroxidase. Arch Biochem Biophys 2000; 379: 147-52.
28. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor FcεRI. Nature 1999; 402: B24-B30.
29. Corry DB, Kheradmand F. Induction and regulation of the IgE response. Nature 1998; 402: B18-B23.
30. Holgate S, Smith N, Massanari M, Jimenez P. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 2009; 64: 1728-36.
31. Hart TK, Blackburn MN, Brigham-Burke M, et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol 2002; 130: 93-100.
32. Kibe A, Inoue H, Fukuyama, S., et al. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003; 167: 50-6.
33. Wynn TA. IL-13 effector functions. Annu Rev Immunol 2003; 21: 425-56.
34. Mattes J, Yang M, Siqueira A, et al. IL-13 induces airways hyperreactivity independently of the IL-4 R alpha chain in the allergic lung. J Immunol 2001; 167: 1683-92.
35. Prieto J, Lensmar C, Roquet A, et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated lowdose allergen provocations. Respir Med 2000; 94: 806-14.
36. Rogerio AP, Fontanari C, Borducchi E, et al. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol 2008; 580: 262-70.
37. Stein ML, Villanueva JM, Buckmeier BK, et al. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol 2008; 121: 1473-83.
38. Chen XH, Zhong NS, Zhang WD, et al. Budesonide attenuates airway remodeling and modules the expression of Janus protein tyrosine kinase 1, and signal transducers and activators of transcription 6 in asthma: an experiment with mice. Zhonghua Yi Xue Za Zhi 2007; 87(23): 1627-32.
39. Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol 1999; 104: S132-7.
40. Moore KW, deWaal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
41. Chai JG, Xue SA, Coe D, et al. Regulatory T cells, derived from naive CD4+CD25-T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79(10): 1310-6.
42. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009; 39: 1314-23.
43. Lentsch AB, Shanley TP, Sarma V, Ward PA. In Vivo Suppression of NFkB and Preservation of IkBa by Interleukin-10 and Interleukin-13. J Clin Invest 1997; 100: 2443-8.
44. Mulligan, MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12 and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997; 159: 3483-9.
45. Jaki BU, Franzblau GS, Chadwick RL, et al. Purity-Activity Relationships of Natural Products: The Case of Anti-TB Active Ursolic Acid. J Nat Prod 2008; 71: 1742-8.